Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating The Use Of Adjuvant Endocrine Therapy +/- One Year Of Everolimus In Patients With H
Posted Date: May 15, 2019
- Investigator: Mahmoud Charif
- Specialties:
- Type of Study: Drug
This study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without patients cancer returning. The current standard treatment after chemotherapy is hormone treatment alone. Everolimus is currently approved for the treatment of advanced or
Criteria:
Eligible Patients Must Have Hormone Responsive Breast Cancer That Has Already Been Removed By Surger
Keywords:
Brca, Breast Cancer, Her2, Metastatic Breast Ca, S1207
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com